Key result
Torque Teno Virus load at one month predicted opportunistic infections between months 1 and 3 (AUC-ROC 0.723; 95% CI 0.559-0.905; p=0.023), but was not associated with maintenance immunosuppression.
Why the study?
Although measuring Torque Teno Virus load allows assessing net immunosuppressive state after kidney transplantation, how exposure to maintenance immunosuppression affects it was unknown.
Does Torque Teno Virus load predict opportunistic infections and correlate with maintenance immunosuppression exposure in kidney transplant patients?
Cohort (n=54)
Does Torque Teno Virus load predict opportunistic infections and correlate with maintenance immunosuppression exposure in kidney transplant patients?
Effect estimate: AUC-ROC 0.723 (95% CI 0.559-0.905)
p-value: p=0.023
TTV load is a useful marker of net immunosuppressive status and predicts opportunistic infections after kidney transplantation, but it is not directly related to the exposure levels of maintenance immunosuppression.
May inform net immunosuppression assessment post-KTx; hypothesis-generating and requires prospective validation before clinical adoption.
Measuring the non-pathogenic Torque Teno Virus (TTV) load allows assessing the net immunosuppressive state after kidney transplantation (KTx). Currently, it is not known how exposure to maintenance immunosuppression affects TTV load. We hypothesized that TTV load is associated with the exposure to mycophenolic acid (MPA) and tacrolimus. We performed a prospective study including 54 consecutive KTx. Blood TTV load was measured by an in-house PCR at months 1 and 3. Together with doses and trough blood levels of tacrolimus and MPA, we calculated the coefficient of variability (CV), time in therapeutic range (TTR) and concentration/dose ratio (C/D) of tacrolimus, and the MPA-area under the curve (AUC-MPA) at the third month. TTV load at the first and third month discriminated those patients at risk of developing opportunistic infections between months 1 and 3 (AUC-ROC 0.723, 95%CI 0.559–0.905, p = 0.023) and between months 3 and 6 (AUC-ROC 0.778, 95%CI 0.599–0.957, p = 0.028), respectively, but not those at risk of acute rejection. TTV load did not relate to mean tacrolimus blood level, CV, TTR, C/D and AUC-MPA. To conclude, although TTV is a useful marker of net immunosuppressive status after KTx, it is not related to exposure to maintenance immunosuppression.
No takes yet. Share an insight, caveat, or question.
Cañamero et al. (2023) conducted a cohort in kidney transplantation (n=54). Torque Teno Virus (TTV) load was evaluated on opportunistic infections between months 1 and 3 (AUC-ROC 0.723, 95% CI 0.559-0.905, p=0.023). Torque Teno Virus load at one month predicted opportunistic infections between months 1 and 3 (AUC-ROC 0.723; 95% CI 0.559-0.905; p=0.023), but was not associated with maintenance immunosuppression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: